Physician profile
Anthony L Mathis
NPI 1407825953
$3,141.60
in general payments reported to CMS, 2019-2025
18 companies · $13.91 in 2025
The $13.91 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,052 · 2020: $1,232 · 2021: $99.73 · 2022: $281 · 2023: $138 · 2024: $325 · 2025: $13.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,681.56 | 2019-2022 | |
| Kerecis Limited | $346.83 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $207.41 | 2019 | |
| Convatec INC. | $163.51 | 2024 | |
| Horizon Therapeutics Plc | $157.62 | 2019-2022 | |
| Globus Medical, INC. | $117.24 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $103.52 | 2023 | |
| Grt US Holding, INC. | $58.51 | 2022 | |
| Polarityte, INC. | $56.81 | 2019 | |
| Dynasplint Systems INC. | $46.88 | 2021 | |
| Integra Lifesciences Corporation | $46.29 | 2019-2021 | |
| Nevro Corp. | $44.97 | 2022-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $31.72 | 2022-2023 | Nuzyra |
| Linvatec Corporation | $23.06 | 2019 | |
| Paragon 28, INC. | $14.78 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $14.73 | 2020 | |
| Abbvie INC. | $13.91 | 2025 | |
| Bioventus LLC | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.